142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

308621
Diabetes and related comorbidities among rural Medicare beneficiaries: Findings from the Medical Expenditure Panel Survey

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Tuesday, November 18, 2014 : 5:30 PM - 5:50 PM

Steven Howard, PhD, MBA , College for Public Health and Social Justice - Department of Health Management & Policy, Saint Louis University, St. Louis, MO
Stephanie Bernell, PhD , Public Health, Oregon State University, Corvallis, OR
Jennifer Wilmott, MSW, MPH , Saint Louis University, St. Louis, MO
Matt Dietz, BS , College for Public Health and Social Justice - Department of Health Management & Policy, Saint Louis University, St. Louis, MO
Samantha Ressler, MPH , College for Public Health and Social Justice - Department of Health Management & Policy, Saint Louis University, St. Louis, MO
Lindsey Pearson, BS , College for Public Health and Social Justice - Department of Health Management & Policy, Saint Louis University, St. Louis, MO
Problem Statement: Diabetes mellitus affects 26 million Americans, and costs the nation an average of $174 billion per year. A previous study (Howard et al, 2014) showed rural Medicare beneficiaries were less likely to have diabetes. However, rural diabetic beneficiaries were three times more likely to have comorbidities. Using Medical Expenditure Panel Survey (MEPS), this study models the effects of rural residence on diabetes and related cardiometabolic conditions.

Methods: Disease diagnosis outcome variables were drawn from the 2004-2011 MEPS Household Component files. Separate logistic regressions were used for beneficiaries and the overall population to model the impact of rural residence on: (1) prevalence of diabetes or other diabetes-related cardiometabolic diagnoses, (2) prevalence of diabetes-related cardiometabolic diseases among diabetics, and (3) incidence of diabetes. Diabetes-related comorbidities in MEPS included hypertension, coronary heart disease, stroke or transient ischemic attack, high cholesterol, diabetes-related eye or kidney disease, angina, and heart attack.

Results: Among beneficiaries and the broader population, rural residence was significantly related to the three disease states previously enumerated.  Rural diabetics were nearly 3 times more likely to have related comorbidities.

Conclusions: Rural residence was associated with lower prevalence of diabetes and related cardiometabolic conditions.  It may be that rural lifestyles are more active, contributing to lower disease burdens, or that reduced access to primary care leaves more rural diabetics undiagnosed.  Increased prevalence of related comorbidities among rural diabetics may be influenced by decreased access to primary care and disease management programs.  Future studies should control for access to these services.

Learning Areas:

Administration, management, leadership
Biostatistics, economics
Chronic disease management and prevention
Provision of health care to the public
Public health or related laws, regulations, standards, or guidelines
Public health or related public policy

Learning Objectives:
Discuss the rural residence impact on health disparities using multiple logistic regression models derived from Medical Expenditure Panel Survey data

Keyword(s): Medicare, Rural Health

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: att Dietz is a Master of Health Administration student at Saint Louis University. He has received a Bachelor of Science in Health Management and Minor in Public Health from Saint Louis University. His graduate research and experience has focused on Medicare and Medicaid policy and its effects on population-level health, Medicaid expansion implications of the Affordable Care Act, and quality improvement models of pediatric outpatient care.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.